Latest news
First-Line Treatment Intensification in EGFR-Mutated NSCLC: Overall Survival Data and Regimen Selection - onclive.comonclive.com · Tue, 11 Aug 2026 03:35:15 GMTEvaluating Response, Durability, and Treatment Selection in High-Risk NMIBC - UroTodayUroToday · Sat, 08 Aug 2026 18:53:20 GMTToxicity Considerations With Third-Line Treatment in KRAS Wild-Type mCRC - Targeted OncologyTargeted Oncology · Fri, 31 Jul 2026 07:00:00 GMTAdvanced Renal Cell Carcinoma: Incorporating Quality of Life into Treatment Sequencing - Targeted OncologyTargeted Oncology · Thu, 30 Jul 2026 07:00:00 GMT